Skip to main content
. 2022 Nov 29;14:1006089. doi: 10.3389/fnagi.2022.1006089

Figure 1.

Figure 1

AD, MS, and ALS exhibit increased inflammation and bioenergetic changes, ultimately leading to neurodegeneration and furthering disease progression. The cross talk between inflammation and bioenergic dysfunction is dynamic and influences one another, promoting dysregulation. Figure created with BioRender.com .